Streetbeat News

Legal

BEN

Franklin Resources, Inc. (NYSE: BEN) is under investigation by Bleichmar Fonti & Auld LLP for potential securities law violations following a CFTC inquiry. Investors are advised to seek more information from the law firm.

Portfolio Pulse from

November 06, 2024 | 12:00 pm

ELAN

A securities fraud class action lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain senior executives for potential violations of federal securities laws. Investors are encouraged to contact Bleichmar Fonti & Auld LLP for more information before the approaching deadline.

Portfolio Pulse from

November 06, 2024 | 12:00 pm

EW

Edwards Lifesciences Corporation investors are being urged to contact BFA Law regarding a securities fraud class action before the December 13, 2024 deadline.

Portfolio Pulse from

November 06, 2024 | 12:00 pm

MGX

Levi & Korsinsky has announced a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX) with a lead plaintiff deadline of November 25, 2024. Investors who suffered losses can seek potential recovery under federal securities laws.

Portfolio Pulse from

November 06, 2024 | 11:45 am

META

The U.S. Supreme Court will hear a case involving Meta's Facebook, which seeks to dismiss a securities fraud lawsuit. Shareholders accuse Facebook of misleading them about user data misuse.

Portfolio Pulse from

November 06, 2024 | 11:30 am

AZN

AstraZeneca is cooperating with Chinese authorities following reports of senior executives' involvement in a major pharmaceutical insurance fraud case, which led to a significant drop in its valuation.

Portfolio Pulse from

November 06, 2024 | 9:30 am

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential securities fraud violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 2025.

Portfolio Pulse from

November 06, 2024 | 9:30 am

MYGN

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Myriad Genetics, Inc. investors. They encourage investors who purchased Myriad securities to participate in the investigation.

Portfolio Pulse from

November 06, 2024 | 9:15 am

AAPL

Apple Inc may face the first fine under the EU's Digital Markets Act due to alleged anti-competitive practices in its App Store. The European Commission charged Apple with violating the DMA by restricting app developers from offering alternative purchasing options.

Portfolio Pulse from

November 06, 2024 | 8:30 am

GMAB

Genmab's strong pipeline and strategic partnerships, particularly with DARZALEX and EPKINLY, support a bullish outlook despite legal issues with Johnson & Johnson. The upcoming Q3 earnings on November 6th are pivotal, with expected revenue of $817M and EPS of $0.33, which could reverse a recent 20% share price decline. Key areas to watch include pipeline updates, operating expenses, DARZALEX royalties, and the impact of the ProfoundBio acquisition.

Portfolio Pulse from

November 06, 2024 | 8:30 am